229 related articles for article (PubMed ID: 35869486)
1. National and transnational drug shortages: a quantitative descriptive study of public registers in Europe and the USA.
Ravela R; Lyles A; Airaksinen M
BMC Health Serv Res; 2022 Jul; 22(1):940. PubMed ID: 35869486
[TBL] [Abstract][Full Text] [Related]
2. State of the European Union's early notification obligation for drug shortages: enforcement and compliance in eight European countries (2020-2022).
Ravela R; Airaksinen M; Lyles A
J Pharm Policy Pract; 2023 Nov; 16(1):135. PubMed ID: 37936250
[TBL] [Abstract][Full Text] [Related]
3. Proposal for Handling of Medicine Shortages Based on a Comparison of Retrospective Risk Analysis.
Turbucz B; Major M; Zelko R; Hanko B
Int J Environ Res Public Health; 2022 Mar; 19(7):. PubMed ID: 35409787
[TBL] [Abstract][Full Text] [Related]
4. Drug shortages in European countries: a trade-off between market attractiveness and cost containment?
Pauwels K; Huys I; Casteels M; Simoens S
BMC Health Serv Res; 2014 Sep; 14():438. PubMed ID: 25257912
[TBL] [Abstract][Full Text] [Related]
5. Shortages of Medicines to Treat COVID-19 Symptoms during the First Wave and Fourth Wave: Analysis of Notifications Reported to Registers in Austria, Italy, and Spain.
Sánchez DIR; Vogler S
Pharmacy (Basel); 2023 Jul; 11(4):. PubMed ID: 37489351
[TBL] [Abstract][Full Text] [Related]
6. Fighting trafficking of falsified and substandard medicinal products in Russia.
Fayzrakhmanov NF
Int J Risk Saf Med; 2015; 27 Suppl 1():S37-40. PubMed ID: 26639702
[TBL] [Abstract][Full Text] [Related]
7. The impact of drug shortages on drug prices: evidence from China.
Hu S; Zhang J; Li J; Zhang J; Pan M; Xiang C; Dave CV; Yang C; Fang Y
Front Public Health; 2023; 11():1185356. PubMed ID: 38026336
[TBL] [Abstract][Full Text] [Related]
8. Drug shortages in China: a cross-sectional study.
Song Y; Li J; Zhao F; Jin P
BMC Health Serv Res; 2023 May; 23(1):438. PubMed ID: 37143100
[TBL] [Abstract][Full Text] [Related]
9. Price comparison of high-cost originator medicines in European countries.
Vogler S; Zimmermann N; Babar ZU
Expert Rev Pharmacoecon Outcomes Res; 2017 Apr; 17(2):221-230. PubMed ID: 27658050
[TBL] [Abstract][Full Text] [Related]
10. Drug affordability-potential tool for comparing illicit drug markets.
Groshkova T; Cunningham A; Royuela L; Singleton N; Saggers T; Sedefov R
Int J Drug Policy; 2018 Jun; 56():187-196. PubMed ID: 29459212
[TBL] [Abstract][Full Text] [Related]
11. How to address medicines shortages: Findings from a cross-sectional study of 24 countries.
Vogler S; Fischer S
Health Policy; 2020 Dec; 124(12):1287-1296. PubMed ID: 33032846
[TBL] [Abstract][Full Text] [Related]
12. Prevention and management of health products shortages by the French national agency (ANSM), 10 years of experience.
Belgodère L; Emmerich J; Albin N; Bacon T; Daynes P; Vignot S; Vial T; Renaud G; Le Saulnier C; Maillard-Couvreur C; Cachet M; Veyries ML; Youdarene R; Oualikene-Gonin W; Ratignier-Carbonneil C; Maison P
Front Public Health; 2023; 11():1293110. PubMed ID: 38045969
[TBL] [Abstract][Full Text] [Related]
13. Drug shortages in low- and middle-income countries: Colombia as a case study.
Sabogal De La Pava ML; Tucker EL
J Pharm Policy Pract; 2022 Jun; 15(1):42. PubMed ID: 35698240
[TBL] [Abstract][Full Text] [Related]
14. Drug shortages in Israel: regulatory perspectives, challenges and solutions.
Schwartzberg E; Ainbinder D; Vishkauzan A; Gamzu R
Isr J Health Policy Res; 2017; 6():17. PubMed ID: 28392910
[TBL] [Abstract][Full Text] [Related]
15. New regulatory strategies to manage medicines shortages in Europe.
Musazzi UM; Di Giorgio D; Minghetti P
Int J Pharm; 2020 Apr; 579():119171. PubMed ID: 32092455
[TBL] [Abstract][Full Text] [Related]
16. Price changes and within-class competition of cancer drugs in the USA and Europe: a comparative analysis.
Vokinger KN; Hwang TJ; Carl DL; Laube Y; Ludwig WD; Naci H; Kesselheim AS
Lancet Oncol; 2022 Apr; 23(4):514-520. PubMed ID: 35271804
[TBL] [Abstract][Full Text] [Related]
17. Factors associated with drug shortages in Canada: a retrospective cohort study.
Zhang W; Guh DP; Sun H; Lynd LD; Hollis A; Grootendorst P; Anis AH
CMAJ Open; 2020; 8(3):E535-E544. PubMed ID: 32873582
[TBL] [Abstract][Full Text] [Related]
18. Systemic Measures and Legislative and Organizational Frameworks Aimed at Preventing or Mitigating Drug Shortages in 28 European and Western Asian Countries.
Bochenek T; Abilova V; Alkan A; Asanin B; de Miguel Beriain I; Besovic Z; Vella Bonanno P; Bucsics A; Davidescu M; De Weerdt E; Duborija-Kovacevic N; Fürst J; Gaga M; Gailīte E; Gulbinovič J; Gürpınar EU; Hankó B; Hargaden V; Hotvedt TA; Hoxha I; Huys I; Inotai A; Jakupi A; Jenzer H; Joppi R; Laius O; Lenormand MC; Makridaki D; Malaj A; Margus K; Marković-Peković V; Miljković N; de Miranda JL; Primožič S; Rajinac D; Schwartz DG; Šebesta R; Simoens S; Slaby J; Sović-Brkičić L; Tesar T; Tzimis L; Warmińska E; Godman B
Front Pharmacol; 2017; 8():942. PubMed ID: 29403372
[TBL] [Abstract][Full Text] [Related]
19. Medicine shortages: Product life cycle phases and characteristics of medicines in short supply-A register study.
Sarnola K; Kari H; Koskinen H
Front Pharmacol; 2022; 13():943249. PubMed ID: 35833029
[No Abstract] [Full Text] [Related]
20. Are vaccine shortages a relevant public health issue in Europe? Results from a survey conducted in the framework of the EU Joint Action on Vaccination.
Filia A; Rota MC; Grossi A; Martinelli D; Prato R; Rezza G
Vaccine; 2022 Mar; 40(13):1987-1995. PubMed ID: 35190211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
